Inactive Instrument

Press Releases Gridiron Bionutrients Inc Other OTC

Equities

US62847K1025

Press Releases

Unlock all the news: Be the first to know and act before the market!

Innovation1 Biotech : New Financial Obligation - Form 8-K	23-10-16	PU
Innovation1 Biotech : Material Agreement - Form 8-K	23-04-24	PU
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-24	AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	23-01-17	AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-12-15	AQ
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-12-12	AQ
INNOVATION1 BIOTECH INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-11-30	AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)	22-11-17	AQ
INNOVATION1 BIOTECH INC. : Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-14	AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)	22-10-25	AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-09-15	AQ
Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors	22-09-15	AQ
Innovation1 Biotech Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction	22-08-18	AQ
Innovation1 Biotech : Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors - Form 8-K	22-08-15	PU
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-08-15	AQ
Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors	22-08-11	AQ
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-07-14	AQ
INNOVATION1 BIOTECH INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-04-27	AQ
INNOVATION1 BIOTECH INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-04-21	AQ
INNOVATION1 BIOTECH INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-04-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Gridiron Bionutrients Inc Other OTC

Equities

US62847K1025

Press Releases

Filters